MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Monoclonal and Polyclonal Antibodies Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,236 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,236 works in the cohort · of 4,299,418page 27 of 45

Labels cover 5 of 2,236 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,236 of 2,236 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
Cap-dependent translation initiation monitored in living cells
Valentina Gandin, Brian P. English, Melanie Freeman, Louis‐Philippe Leroux, Stephan Preibisch, Deepika Walpita +2 more
2021· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Geometric Epitope and Paratope Prediction
Marco Pegoraro, Clémentine Dominé, Emanuele Rodolà, Petar Veličković, Andreea Deac
2023· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Nevirapine Hypersensitivity
J.M. Shenton, M. Popovic, J.P. Uetrecht
2007· book-chapter· en· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Americas Antibody Congress
Susan E. Lacy, Christopher J. Bond, Dennis R. Benjamin, Hans‐Peter Gerber, Dimiter S. Dimitrov, Janice M. Reichert
2009· article· en· mAbs· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Abstract CT205: Updated clinical results, recommended phase 2 dose (RP2D) determination and translational study results for START-001: A phase 1/2 trial of invikafusp alfa, a first-in-class TCR b chain-targeted bispecific antibody in patients with anti-PD(L)1-resistant, antigen-rich solid tumors
Ryan J. Sullivan, Claire F. Friedman, Jeffrey Schlom, Yo-Ting Tsai, Renee N. Donahue, Guru P. Sonpavde +13 more
2025· article· en· Cancer Research· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Antibodies as drugs—a Keystone Symposia report
Jennifer Cable, Erica Ollmann Saphire, Adrian Hayday, Timothy D. Wiltshire, Jarrod J. Mousa, David P. Humphreys +25 more
2022· article· en· Annals of the New York Academy of Sciences· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affno abstractunlabeled
Structure and Function of the B-Cell Antigen Receptor
Anthony DeFranco, Jonathan Blum, Tracy L. Stevens, Debbie A. Law, Vivien W. Chan, Shaun P. Foy +2 more
2015· article· en· Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affno abstractunlabeled
Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer
Ursula Wiedermann, Erika Garner‐Spitzer, Yee Chao, Iurie Bulat, Arunee Dechaphunkul, Wichit Arpornwirat +14 more
2019· article· en· Annals of Oncology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations

How this was built: Screen · Findings · About